1 Min Read
June 27 (Reuters) - REDWOOD PHARMA AB
* IN TOTAL, COMPANY WILL RECEIVE PROCEEDS OF SEK 9.8 MILLION BEFORE ISSUE COSTS THROUGH THE RIGHTS ISSUE Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.